July 21th (Sat.)
Opening Address (2:30 pm)
Keynote Lecture (2:20 pm ~ 3:05 pm)
"Chrono-nutrition and health science"
Shigenobu Shibata (Waseda University, Japan)
Oral Sessions (3:05 pm ~ 5:30 pm)
1-1 "AHCC® controls oncomir-155 via cancer stem cells-mediated breast cancer chemoresistance mechanisms"
Chantal Matar (University of Ottawa, Canada)
1-3 "Suppressive effects of AHCC® on the growth of breast cancer patient-derived xenograft in super-SCID mice"
Taisei Nomura (National Institutes of Biomedical Innovation, Health and Nutrition, Japan)
1-4 "The impact of AHCC® on anti-cancer effect, adverse events, and quality of life in patients with locoregionally advanced nasopharyngeal carcinoma throughout induction chemotherapy: Matched case-control study"
Ping Li (Sichuan University, China)
1-5 "Preliminary report on the phase II randomized, double-blind, placebo-controlled evaluation of AHCC® for the eradication of HPV infections in women with HPV positive pap smears"
Judith A. Smith (UTHealth McGovern Medical School, USA)
1-6 "Oligonol® alleviates sarcopenia: Mechanisms of mitochondrial dynamic and autophagic flux"
Sue-Joan Chang (National Cheng Kung University, Taiwan)
1-7 "Effects of Oligonol® on the blood flow and the physical function in clinical trial"
Hideaki Waki (Teikyo Heisei University, Japan)
1-8 "The effect of Oligonol® in non-alcoholic fatty liver disease patients: Preliminary report"
Satien Techapaitoon (Bumrungrad International Hospital, Thailand)
Poster Sessions (6:00 pm ~ 7:00 pm)
PA-1 "Effect of AHCC® on the in situ and metastasis of nude mice with 4T1-GFP-luc breast cancer cells"
Du Jian (The Fujian University of Traditional Chinese Medicine, China)
PA-2 "Study of the metabolism spectrum of malignant and thyroid formations and prospects of using AHCC® in the treatment"
Zhangenthan Abylaiuly (Kazakh National Medical University, Kazakhstan)
PA-3 "Molecular and genetic studies of thyroid gland cancer and clinical experience of using AHCC®"
Askar Tlegenov (Kazakh National Medical University, Kazakhstan)
PA-4 "Evaluation of AHCC® clinical effect in the treatment of patients with Hashimoto’s thyroiditis"
Zaure Zhaparkhanova (Center of Endocrinology, Kazakhstan)
PA-5 "AHCC® in childhood Sarcoidosis with implications for atopy and Sjögren's disease"
Francisco Karkow (Fátima’s Faculty, Brazil)
PA-6 "Clinical outcomes of AHCC® and its effect on chemotherapy related adverse events in patients with unresectable pancreatic cancer"
Anarkhuu Bold-Erdene (National Cancer Center of Mongolia, Mongolia)
PA-7 "Mitigation effects of discomforts by AHCC® in an inoperable Japanese female with lymph node metastasis after the excisions of thyroid cancer"
Masaru Murata (Health Sciences University of Hokkaido, Japan)
PA-8 "Effects of combined administration of AHCC® and GCP® in cases of intractable pulmonary MAC (Mycobacterium avium-intracellulare complex)"
Kentaro Wakamatsu (Omuta Hospital, Japan)
PA-9 "Efficacy of AHCC® in female breast cancer patients undergoing adjuvant chemotherapy"
Reo Hamaguchi (The University of Tokyo, Japan)
PB-1 "Long-term administration of AHCC® as a dietary supplement to a patient after breast cancer surgery and chemotherapy: A case report"
Erina Nakamura (Hokkaido University of Science, Japan)
PB-2 "Investigation into the effects of AHCC® on perceived abnormalities in taste in patients undergoing chemotherapy for pancreatic cancer: Randomized study mid-term report"
Hiroaki Yanagimoto (Kansai Medical University, Japan)
PB-3 "Antioxidant and antitumor activities of Oligonol®"
Yoshihiro Mihara (Hokkaido University of Science, Japan)
PB-4 "Treatment of Oligonol® attenuates levels of acetyl-CoA carboxylase, a rete limiting enzyme of lipogenesis, in 3T3-L1 pre-adipocytes"
Amire Alimu (Asahikawa Medical University, Japan)
PB-5 "Oligonol® suppresses the activation of hepatic stellate cell by inhibition of YAP/TAZ pathway"
Hayato Urushima (Osaka City University, Japan)
PB-6 "Bioavailability and metabolism of Oligonol® in rats"
Kyoichi Osada (Meiji University, Japan)
PB-7 "The mitigating effects of Oligonol® on menstrual distress: A double blind, randomized placebo-controlled trial"
Masaki Taga (Wayo Women’s University, Japan)
PB-8 "Effects of Oligonol® on body weight and body fat reduction: A double-blind, randomized, controlled trial study in healthy adults"
Honami Oya (Fuji Women's University, Japan)
PB-9 "Effect of ingestion of perilla extract on pollinosis caused by Japanese white birch (Betula platyphylla var. japonica) in randomized, double-blind, placebo-controlled study"
Naohito Ito (Hokkaido Information University, Japan)
PC-1 "ETAS®50 prevents ultraviolet-B irradiation-induced reduction in heat shock protein 70 expression in normal human dermal fibroblasts"
Ken Shirato (Kyorin University, Japan)
PC-2 "The effect of ETAS®50 on expression of heat shock protein 27 in pancreatic cancer cells"
Yuta Nanimoto (Yamaguchi University, Japan)
PC-3 "Anti-stress effect of ETAS®50 administration: Alteration of HSP70 expression in rat brain"
Kanako Takahashi (University of Tsukuba,Japan)
PC-4 "Protective effects of horseradish leave extracts on cholic acid-induced large intestine damage in mice"
Tomoko Koda (Tokyo Healthcare University, Japan)
PC-5 "Effect of Portulaca oleracea yeast extract on healthy volunteers in clinical trial"
Tatsuya Hisajima (Teikyo Heisei University, Japan)
PC-6 "Characterization of origomeric flavonoids as a novel class of anti-hepatitis B virus entry inhibitors that directly target viral envelope protein"
Senko Tsukuda (National Institute of Infectious Diseases, Japan)
PC-7 "Benefit of lipopolysaccharide (LPS) as an ingredient of functional foods"
Hiroyuki Inagawa (Control of Innate Immunity Technology Research Associate, Japan)
PC-8 "Pro-immune efficacy by rapid and simultaneous dormancy-broken grape seed endosperm"
Toshihiro Ona (Kyushu University, Japan)
PD-1 "Effect of Rhodiola crenulata on cognitive performance and related signaling pathway in senescence-accelerated mouse prone 8"
Yin-Ching Chan (Providence University, Taiwan)
PD-2 "Obesity as a major health problem in Saudi Arabia: Precipitating factors, associated health consequences, and possible solutions"
Hanan Jambi (King Abdulaziz University, Saudi Arabia)
PD-3 "New assessment of the quality of life and neural cognitive function after spontaneous hemorrhagic stroke by using novel quantitative multimodal MRI"
Jiun-Lin Yan (Chang Gung Memorial Hospital, Taiwan)
PD-4 "Curcumin protects liver inflammation by suppressing iNOS induction in rat hepatocytes"
Richi Nakatake (Kansai Medical University, Japan)
PD-5 "Effects of the wolfberries (the fruits of Lycium barbarum) and their constituent on nitric oxide production in interleukin-1β-treated rat hepatocytes"
Tetsuya Okuyama (Ritsumeikan University, Japan)
PD-6 "The effect of intake of Cirsium brevicaule on lipid metabolism"
Miki Sakaue (Osaka University, Japan)
PD-7 "A comprehensive metabolomic analysis of mulberry leaves components and their inhibitory effects on blood glucose level elevation in humans"
Shino Nagaki (Hokkaido University of Science, Japan)
PD-8 "Effect of ingestion of rare sugar syrup on the blood glucose response in adult healthy humans; the evidence supports a health claim"
Takako Yamada (Matsutani Chemical Industry Co., Ltd., Japan)
July 22th (Sun)
Oral Sessions (9:00 am ~ noon)
2-1 "Anti-inflammatory and proresolving natural products with cancer preventive potential"
Young-Joon Surh (Seoul National University, South Korea)
2-2 "Multiorgan-protective function of ETAS®50 against cellular stresses in vivo; cisplatin-induced nephrotoxicity and amyloid-beta-mediated neurotoxicity"
Toshihiko Torigoe (Sapporo Medical University, Japan)
2-3 "Basic studies for the effect of ETAS® on sleep"
Shoichiro Inoue (Otsuka Pharmaceutical Co., Ltd., Japan)
2-4 "Effect of ETAS®50 in predementia cognitive disorder in young age"
Natalia Mikhailichenko (Nevron International Medical Center, Russia)
2-5 "A microliter-scale high-throughput screening system of amyloid β aggregation inhibitors"
Kiyotaka Tokuraku (Muroran Institute of Technology, Japan)
2-6 "Constituents in perilla extract inhibit production of nitric oxide in rat hepatocytes"
Yukinobu Ikeya (Daiichi University of Pharmacy, Japan)
2-7 "The effects of AHCC® on T cells in health and disease"
Insoo Kang (Yale University, USA)
2-8 "Clinical safety and efficacy of AHCC® in pulmonary MAC diseases"
Masaki Fuijta (Fukuoka University Hospital, Japan)
2-9 "Reduction of adverse effects by AHCC® in patients with breast cancer during chemotherapy: A placebo-controlled, randomized, double-blind clinical trial"
Satoshi Ohno (Osaka University, Japan)
Public Symposium (1:00 pm ~ 3:00 pm)
Closing Address (3:00 pm)